ZAGIDULLIN, N.SH.,
MOTLOCH, LUKAS J,,
GAREEVA, D.F.,
HAMITOVA, AYSILU,
LAKMAN, I.A.,
KRIONI, ILJA,
POPOV, DENIS,
ZULKARNEEV, R.KH.,
PAAR, VERA,
KOPP, KRISTEN,
JIRAK, PETER,
ISHMETOV, V.SH.,
HOPPE, UTA C.,
TULBAEV, EDUARD,
V.N. Pavlov (2020) worldwide. In addition to the classic biomarker NT-proBNP,
new biomarkers like ST2 and Pentraxin-3 (Ptx-3
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) for the treatment of cardiac conduction delay and provides a
new idea of treating arrhythmia with a drug.